State of the art in the treatment of laryngeal cancer

Anticancer Research

Volumn 33, Issue 11, 2013, Pages 4701-4710

  Jenckel, Friederike ^a   Knecht, Rainald ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Laryngeal cancer; Larynx preservation; Organ preservating surgery; Radiochemotherapy

Indexed keywords

ALPHA2B INTERFERON; ANTISENSE OLIGONUCLEOTIDE; CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; HYDROXYUREA; MONOCLONAL ANTIBODY;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CHEMORADIOTHERAPY; CONSERVATIVE TREATMENT; ENDOSCOPIC SURGERY; HUMAN; INDUCTION CHEMOTHERAPY; LARYNGECTOMY; LARYNX; LARYNX CANCER; LASER SURGERY; MOLECULARLY TARGETED THERAPY; ORGAN PRESERVATION; PRIORITY JOURNAL; REVIEW; ROBOTICS; SUPRACRICOID PARTIAL LARYNGECTOMY; SUPRAGLOTTIC LARYNGECTOMY; TRACHEA STOMA; TRANSORAL ROBOTIC SURGERY; VERTICAL PARTIAL LARYNGECTOMY;

LARYNGEAL CANCER; LARYNX PRESERVATION; ORGAN-PRESERVATING SURGERY; RADIOCHEMOTHERAPY;

ANIMALS; COMBINED MODALITY THERAPY; HUMANS; LARYNGEAL NEOPLASMS; PROGNOSIS;

EID: 84891355009     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Terrell J, Fisher S and Wolf G: Long-term quality of life after treatment of laryngeal cancer. Arch Otolaryngol Head Neck Surg 124: 964-971, 2011.
2. Silver CE, Beitler JJ, Shaha AR, Rinaldo A and Ferlito A: Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otolaryngol 266: 1333-1352, 2009.
3. Stoeckli SJ, Pawlik AB, Lipp M, Huber A and Schmid S: Salvage surgery after failure of nonsurgical therapy for carcinoma of the larynx and hypopharynx. Arch Otolaryngol Head Neck Surg 126: 1473-1477, 2000.
4. Holsinger FC, Funk E, Roberts DB and Diaz EM Jr.: Conservation laryngeal surgery versus total laryngectomy for radiation failure in laryngeal cancer. Head Neck 28: 779-784, 2006.
5. Ganly I, Patel SG, Matsuo J, Singh B, Kraus DH, Boyle JO, Wong RJ, Lee N, Shaha AR and Shah JP: Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx. Arch Otolaryngol Head Neck Surg 132: 59-66, 2006.
6. The Department of Veterans Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324: 1685-1690, 1991.
7. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L and Sahmoud T: Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88: 890-899, 1996.
8. Gößler UR: Grundlagen und klinische Bedeutung der klassischen transzervikalen Chirurgie von Kopf-Hals-Tumoren-Teilresektionen, Laryngektomie, Rekonstruktionstechniken, Rettungschirurgie. Laryngo-Rhino-Otol 91(S 01): S63-S85, 2012.
9. Piquet JC and Piquet JJ: Partial vertical laryngectomy in cancer of the larynx. Laryngoscope 73: 1351-1369, 1963.
10. Ogura J and Dedo H: Glottic reconstruction following subtotal glottic-supraglottic laryngectomy. Laryngoscope 75: 865-878, 1965.
11. Hiroto I, Mitsuhashi S, Ichikawa A and Kurokawa H: Functional conservative surgery for laryngeal carcinoma-partial laryngectomy. Gan no Rinsho 17: 121-124, 1971 (in Japanese).
12. Yiotakis J, Stavroulaki P, Nikolopoulos T, Manolopoulos L, Kandiloros D, Ferekidis E and Adamopoulos G: Partial laryngectomy after irradiation failure. Otolaryngol Head Neck Surg 128: 200-209, 2003.
13. Weinstein GS, Laccourreye O, Brasnu D and Laccoureye H: Organ Preservation Surgery for Laryngeal Cancer. Singular Publishing Group, San Diego, Ca, USA, 2000.
14. Rodrigo JP, Coca-Pelaz A and Suarez C: The current role of partial surgery as a strategy for functional preservation in laryngeal carcinoma. Acta Otorrinolaringol Esp 62(3): 231-238, 2011.
15. Johnson JT, Hao S, Myers EN and Wagner RL: Outcome of open surgical therapy for glottic carcinoma. Ann Otol Rhinol Laryngol 102: 752-755, 1993.
16. Thomas JV, Olsen KD, Neel HB, DeSanto LW and Suman VJ: Early glottic carcinoma treated with open laryngeal procedures. Arch Otolaryngol Head Neck Surg 120: 264-268, 1994.
17. Brumund KT, Gutierrez-Fonseca R, Garcia D, Babin E, Hans S and Laccourreye O: Frontolateral vertical partial laryngectomy without tracheotomy for invasive squamous cell carcinoma of the true vocal cord: A 25-year experience. Ann Otol Rhinol Laryngol 114: 314-322, 2005.
18. Kessler DJ, Trapp TK and Calcaterra TC: The treatment of T3 glottic carcinoma with vertical partial laryngectomy. Arch Otolaryngol Head Neck Surg 113: 1196-1199, 1987.
19. Biller HF and Lawson W: Partial laryngectomy for vocal cord cancer with marked limitation or fixation of the vocal cord. Laryngoscope 96: 61-64, 1986.
20. Karatzanis AD, Psychogios G, Zenk J, Waldfahrer F, Hornung J and Velegrakis GA: Comparison among different available surgical approaches in T1 glottic cancer. Laryngoscope 119: 1704-1708, 2009.
21. Alonso JM: Conservative surgery of the larynx. Trans Am Acad Ophthalm Otolaryngol 51: 633-642, 1947.
22. Alonso CM and Jackson CL: Conservation of function in surgery of cancer of the Larynx: Bases, technique and results. Trans Am Acad Ophthalmol Otolaryngol 56: 722, 1952.
23. Sevilla MA, Rodrigo JP, Llorente JL, Cabanillas R, López F and Suárez C: Supraglottic laryngectomy: analysis of 267 cases. Eur Arch Otorhinolaryngol 265: 11-16, 2008.
24. Scola B, Fernandez-Vega M, Martinez T, Fernandez-Vega S and Ramirez C: Management of cancer of the supraglottis. Otolaryngol Head Neck Surg 124: 195-198, 2001.
25. Herranz J, Martinez Vidal J and Martinez Moran A: Supraglottic laryngectomy. Still on-going. Acta Otorrinolaringol Esp 57: 235-241, 2006.
26. Herranz González-Botas J, Gavilan Bouzas J and Martínez Vidal J: Laringuectomía supraglótica: resultados a 3 y 5 anos. Acta Otorrinolaringol Esp 50: 269-275, 1999.
27. Robbins KT, Davidson W, Peters LJ and Goepfert H: Conservation surgery for T2 and T3 carcinomas of the supraglottic larynx. Arch Otolaryngol Head Neck Surg 114: 421-426, 1988.
28. Sessions DG, Lenox J and Spector GJ: Supraglottic laryngeal cancer: analysis of treatment results. Laryngoscope 115: 1402-1410, 2005.
29. Prades JM, Simon PG, Timoshenko AP, Dumollard JM, Schmitt T and Martin C: Extended and standard supraglottic laryngectomies: A review of 110 patients. Eur Arch Otorhinolaryngol 262: 947-952, 2005.
30. Suárez C, Rodrigo JP, Herranz J, Llorente JL and Martínez JA: Supraglottic laryngectomy with or without postoperative radiotherapy in supraglottic carcinomas. Ann Otol Rhinol Laryngol 104: 358-363, 1995.
31. Rodrigo JP, Suárez C, Silver CE, Rinaldo A, Ambrosch P, Fagan JJ, Genden EM and Ferlito A: Transoral laser surgery for supraglottic cancer. Head Neck 30: 658-666, 2008.
32. Majer H and Rieder A: Technique de laryngectomie permetant de conserver la permeabilite respiratoire. (La crico-hyoidopexie). Ann Otolaryngol Chir Cervicofac 76: 677-683, 1959.
33. Laccourreye O, Salzer S, Brasnu D, Shen W, Laccourreye H and Weinstein G: Glottic carcinoma with a fixed true vocal cord-outcomes following chemotherapy and supracricoid partial laryngectomy with cricohyoidoepiglottopexy. Otolaryngol Head Neck Surg 3: 400-406, 1996.
34. Laccourreye O, Laccourreye L, Garcia D, Gutierrez-Fonseca R, Brasnu D and Weinstein G: Vertical partial laryngectomy versus supracricoid partial laryngectomy for selected carcinomas of the true cord classified as T2N0. Ann Otol Rhinol Laryngol 109: 965-971, 2000.
35. Nakayama M, Laccourreye O, Holsinger FC, Okamoto M and Hayakawa K: Functional organ preservation for laryngeal cancer: Past, present and future. J Clin Oncol 42(3): 155-160, 2012.
36. Hartl DM, Ferlito A, Brasnu DF, Langendijk JA, Rinaldo A, Silver E and Wolf GT: Evidence-based review of treatment options for patients with glottis cancer. Head Neck 33, 2011
37. Castro A, Sanchez-Cuadrado I, Bernaldez R, Del Palacio A and Gavilan J: Larynx function preservation following supracricoid partial laryngectomy. Head Neck 34: 162-167, 2012.
38. Naudo P, Laccourreye O, Weinstein GS, Hans S, Laccourreye H, Brasnu D. Functional outcome and pronostic factors after supracricoid partial laryngectomy with cricohyoidopexy. Ann Otol Rhinol Laryngol 106: 291-296, 1997.
39. Weinstein GS, O'Malley BW, Magnuson JS, Carroll WR, Olsen KD, Daio L, Moore EJ and Holsinger FC: Transoral robotic surgery: A multicenter study to assess feasibility, safety, and surgical margins. Laryngoscope 122(8): 1701-1707, 2012.
40. Park YM, Lee WJ, Lee JG, Lee WS et al: Transoral robotic surgery (TORS) in laryngeal and hypopharyngeal cancer. J Laparoendosc Adv Surg Tech A 19(3): 361-368, 2009.
41. Weinstein GS, O'Malley BW, Snyder W and Hockstein N: Transoral robotic surgery: supraglottic partial laryngectomy. Ann Otol Rhinol Laryngol. 116(1): 19-23, 2007.
42. Steiner W and Ambrosch P: Endoscopic Laser Surgery of the Upper Aerodigestive tract-with Special Emphasis on Cancer Surgery. New York, Georg Thieme, 2000.
43. Rudert HH, Werner JA and Höft S: Transoral carbon dioxide laser resection of supraglottic carcinoma. Ann Otol Rhinol Laryngol 108: 819-827, 1999.
44. American Society of Clinical Oncology, Pfister DG, Laurie SA, et al: American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 24: 3693-3704, 2006.
45. Eckel HE: Endoscopic laser resection of supraglottic carcinoma. Otolaryngol Head Neck Surg 117: 681-687, 1997.
46. Iro H, Waldfahrer F, Altendorf-Hofmann A, Weidenbecher M, Sauer R and Steiner W: Transoral laser surgery of supraglottic cancer: follow-up of 141 patients. Arch Otolaryngol Head Neck Surg 124: 1245-1250, 1998.
47. Steiner W, Vogt P, Ambrosch P and Kron M: Transoral carbon dioxide laser microsurgery for recurrent glottic carcinoma after radiotherapy. Head Neck 26: 477-484, 2004.
48. 2 laser treatment for T(is)-T3 glottic cancer: the University of Brescia experience on 595 patients. Head Neck 32(8): 977-983, 2010.
49. Steiner W, Ambrosch P, Rödel RM and Kron M: Impact of anterior commissure involvement on local control of early glottic carcinoma treated by laser microresection. Laryngoscope 114: 1485-1491, 2004.
50. Hinni ML, Salassa JR, Grant DG, Pearson BW, Hayden RE, Martin A, Christiansen H, Haughey B, Nussenbaum B and Steine W: Transoral laser microsurgery for advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 133: 1198-1204, 2007.
51. 2 laser: Laboratory experiments and clinical experience. Laryngoscope 88(9 Pt 1): 1399-1420, 1978.
52. 2 laser microsurgery for Tis-T3 supraglottic squamous cell carcinomas. Eur Arch Otorhinolaryngol 267(11): 1735-1742, 2010.
53. 2 laser surgery for supraglottic cancer. Eur Arch Otorhinolaryngology 269(9): 2081-2086, 2012.
54. Mendenhall WM, Amdur RJ, Morris CG and Hinerman RW: T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 19: 4029-4036, 2001.
55. Smee RI, Meagher NS, Williams JR, Broadley K and Bridger GP: Role of radiotherapy in early glottic carcinoma. Head Neck 32: 850-859, 2009.
56. Cellai E, Frata P, Magrini SM et al: Radical radiotherapy for early glottic cancer: results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease. Int J Radiat Oncol Biol Phys 63: 1378-1386, 2005.
57. Jones DA, Mendenhall CM, Kirwan J, Morris CG, Donnan A, Kraus ST, Mann CJ, Holwerda S, Grant JR, Donnan B and Mendenhall WM: Radiation therapy for management of T1-T2 glottic cancer at a private practice. Am J Clin Oncol 33(6): 587-590, 2010.
58. Le QT, Fu KK, Kroll S, Ryu JK, Quivey JM, Meyler TS, Krieg RM and Philipps TL: Influence of time and fractionation on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys 39: 1-2, 1997.
59. Johansen LV, Overgaard J, Hjelan-Hansen N and Gadeberg CC: Primary radiotherapy for T1 squamous cell carcinoma of the larynx: analysis of 478 patients treated from 1963 to 1985. Int J Radiat Oncol Biol Phys 18: 1307-1313, 1990.
60. Wang CC and Efird JT: Does prolonged treatment course adversely affect local control of carcinoma of the larynx? Int J Radiat Oncol Biol Phys 29: 657-660, 1994.
61. Mittal B, Rao DV, Marks JE and Perez CA: Role of radiation in the management of early vocal carcinoma. Int J Radiat Oncol Biol Phys 9: 997-1002, 1983.
62. Harwood AR: Cancer of the larynx. The Toronto experience. J Otolaryngol Suppl 11: 3-21, 1982.
63. Fernberg JO, Ringborg U, Silversward C, Ewert G, Haglund S, Schiratzki H and Strander H: Radiation therapy in early glottic cancer. Analysis of 177 consecutive cases. Acta Otolaryngol 108: 478-481, 1989.
64. Sjögren EV, Wiggenraad RG, Le Cessie S, Snijder S, Pomp J and de Jong RJ: Outcome of radiotherapy in T1 glottic carcinoma: a population-based study. Eur Arch Otorhinolaryngol 266: 735-744, 2009.
65. Dinshaw KA, Sharma V, Agarwal JP, Ghoshi S and Havaldar R: Radiation therapy in T1-T2 glottic carcinoma: influence of various treatment parameters on local control/complications. Int J Radiat Oncol Biol Phys 48: 723-735, 2000.
66. Groome PA, O'Sullivan B, Mackillop WJ et al: Compromised local control due to treatment interruptions and late treatment breaks in early glottic cancer: population-based outcomes study supporting need for intensified treatment schedules. Int J Radiat Oncol Biol Phys 64: 1002-1012, 2006.
67. Jin J, Liao ZM, Gao L, Huang XD and Xu GZ: Analysis of prognostic factors for T1N0M0 glottic cancer treated with definitive radiotherapy alone: experience of the cancer hospital of Peking Union Medical College and the Chinese Academy of Medical Sciences. Int J Radiat Oncol Biol Phys 54: 471-478, 2002.
68. Howell-Burke D, Peters LJ, Goepfert H and Oswald MJ: T2 glottic carcinoma: recurrence, salvage, and survival after definitive radiotherapy.Arch Otolaryngol Head Neck Surg 116: 830-835, 1990.
69. Karim ABMF, Kralendonk JH, Yap LY, Njo KH, Tierie AH, Tiwari RM, Snow GB, Gerritsen GJ and hasman A: Heterogeneity of stage II glottic carcinoma and its therapeutic implications. Int J Radiat Oncol Biol Phys 13: 313-317, 1987.
70. Kaplan MJ, Johns ME, McLean WC, Fitz-Hugh GS, Clark DA, Boyd JC and Cantrell RW: Stage II glottic carcinoma: prognostic factors and management. Laryngoscope 93: 725-728, 1983.
71. Mantravadi RVP, Liebner EJ, Haas RE, Skolnik EM and Appelbaum EL: Cancer of the glottis: prognostic factors in radiation therapy. Radiology 149: 311-314, 1983.
72. Harwood AR and DeBoer G: Prognostic factors in T2 glottic cancer. Cancer 45: 991-995, 1980.
73. Hendrickson FR: Radiation therapy treatment of larynx cancers. Cancer 55: 2058-2061, 1985.
74. Bron LP, Soldati D, Zouhair A, Ozsahin M, Brossard E, Monnier P and Pasche P: Treatment of early stage squamous-cell carcinoma of the glottic larynx: endoscopic surgery or cricohyoidoepiglottopexy versus radiotherapy. Head Neck 23: 823-829, 2001.
75. Zohar Y, Rahima M, Shvili Y, Talmi YP and Lurie H: The controversial treatment of anterior commissure carcinoma of the larynx. Laryngoscope 102: 69-72, 1992.
76. Rucci L, Gallo O and Fini-Storchi O: Glottic cancer involving anterior commissur: surgery vs. radiotherapy. Head Neck 13(5): 403-410, 1991.
77. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W et al: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349(22): 2091-2098, 2003.
78. Forastiere AA, Maor M, Weber RS, Pajak T, Glisson B, Trotti A et al: (2006) Long-term results of Intergroup RTOG 91-11: A phase Eur Arch Otorhinolaryngol (2011) 268: 481-487 487 III trial to preserve the larynx-induction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy. ASCO Meeting Abstracts 24(18 Suppl): 5517.
79. Lefebvre JL, Rolland F, Tesselaar M, Bardet E, Leemans CR, GeoVrois L et al: Phase III randomized trial on larynx preservation comparing sequential vs. alternating chemotherapy and radiotherapy. J Natl Cancer Inst 101(3): 142-152, 2009.
80. Mantz CA, Vokes EE, Kies MS, Mittal B, Witt ME, List MA, Weichselbaum RR and Haraf DJ: Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer. Ann Oncol 12(3): 343-347, 2001.
81. Pointreau Y, Garaud P, Chapet S, Sire C, Tuchais C, Tortochaux J, Faivre S, Guerrif S, Alfonsi M and Calais G: Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 101(7): 498-506, 2009.
82. Posner MR, Norris CM, Wirth LJ, Shin DM, Cullen KJ, Winquist EW et al: Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. Ann Oncol 20(5): 921-927, 2009.
83. Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M et al: Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357(17): 1695-1704, 2007.
84. Forastiere AA, Weber RS, Maor M, Goepfert H et al: Long-term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment strategies to Preserve the Larynx in Patients With Locally advanced Larynx Cancer. J Clin Oncol 30: 1-9, 2012.
85. Pomerantz RG and Grandis JR: The epidermal growth factor receptor signaling network in head and neck carcinogenesis and implications for targeted therapy. Semin Oncol 31(6): 734-743, 2004.
86. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB et al: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354(6): 567-578, 2006.
87. Silver CE, Beitler JJ, Shaha AR, Rinaldo A and Ferlito A: Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol 266(9): 1333-1352, 2009.
88. Wolf GTHW, Gross Fisher S: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer (The Department of Veterans AVairs [VA] Laryngeal Cancer Study Group). N Engl J Med 324: 1685-1690, 1991.
89. Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, Ang KK et al: American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 24(22): 3693-3704, 2006.
90. Beitler JJ and Cooper JS: Seduction by induction? J Clin Oncol 27(1): 9-10, 2009.
91. Levebvre JL, Pointreau Y and Rolland F: Induction chemotherapy followed either chemoradiotherapy or bioradiotherapy for larynx Preservation: the TREMPLIN randomized phase II study. J CliniOncol 31: 853-859, 2013.
92. Ambrosch P, Kron M and Steiner W: Carbon dioxide laser microsuergery for early supraglottic carcinoma. Ann Otol Rhinol Laryngol 107(8): 680-688, 1998.